News | December 14, 2022
Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
The investment will enable the company to enter European markets as well as enhance margins in current markets
The investment will enable the company to enter European markets as well as enhance margins in current markets
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
The approval further strengthens the Potassium Chloride franchise for the company.
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Plans to double its manufacturing footprint to bolster the growth
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
